Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs

Sustained virologic response rates have increased dramatically following direct acting antiviral (DAA) therapy in chronic HCV infection. However, resistance-associated substitutions (RASs) may occur either prior to DAA or following drug exposure. The aim of this study was to determine RASs in DAA tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Paolucci, Stefania, Premoli, Marta, Novati, Stefano, Gulminetti, Roberto, Maserati, Renato, Barbarini, Giorgio, Sacchi, Paolo, Piralla, Antonio, Sassera, Davide, De Marco, Leone, Girello, Alessia, Mondelli, Mario U., Baldanti, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700050/
https://www.ncbi.nlm.nih.gov/pubmed/29167469
http://dx.doi.org/10.1038/s41598-017-15987-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700050/
https://www.ncbi.nlm.nih.gov/pubmed/29167469
http://dx.doi.org/10.1038/s41598-017-15987-1

Ejemplares similares